Published in J Clin Endocrinol Metab on December 01, 2000
Activating autoantibodies against the calcium-sensing receptor detected in two patients with autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab (2009) 1.55
Autoimmune polyendocrine syndromes: clues to type 1 diabetes pathogenesis. Immunity (2010) 1.03
Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen. Proc Natl Acad Sci U S A (2009) 1.01
Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a model disease to study molecular aspects of endocrine autoimmunity. Clin Exp Immunol (2004) 0.97
Type 1 diabetes and polyglandular autoimmune syndrome: A review. World J Diabetes (2015) 0.82
Human APECED; a Sick Thymus Syndrome? Front Immunol (2013) 0.82
Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1. Sci Rep (2016) 0.81
Mapping of human autoantibody binding sites on the calcium-sensing receptor. J Bone Miner Res (2010) 0.81
Clues to immune tolerance: the monogenic autoimmune syndromes. Ann N Y Acad Sci (2010) 0.80
Ovarian autoimmune disease: clinical concepts and animal models. Cell Mol Immunol (2014) 0.80
Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: insights into genotype-phenotype correlation. Int J Endocrinol (2012) 0.78
APECED: A Paradigm of Complex Interactions between Genetic Background and Susceptibility Factors. Front Immunol (2013) 0.77
Type 1 Diabetes in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Syndrome (APECED): A "Rare" Manifestation in a "Rare" Disease. Int J Mol Sci (2016) 0.75
A novel mutation associated with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Ann Allergy Asthma Immunol (2008) 0.75
The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet (2000) 15.19
Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care (2001) 14.03
Ulex europaeus I lectin as a marker for vascular endothelium in human tissues. Lab Invest (1982) 3.29
Direct detection of Mycobacterium tuberculosis complex in respiratory specimens by Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test and Roche Amplicor Mycobacterium Tuberculosis Test. J Clin Microbiol (1995) 3.28
Local denervation atrophy of paraspinal muscles in postoperative failed back syndrome. Spine (Phila Pa 1976) (1993) 3.27
The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J (1995) 3.16
Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med (1990) 2.96
Different Ly antigen phenotypes of in vitro induced helper and suppressor cells. Nature (1975) 2.91
A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. N Engl J Med (1992) 2.86
Hereditary diseases in Finland; rare flora in rare soul. Ann Clin Res (1973) 2.75
Comparison of manual Amplicor PCR, Cobas Amplicor PCR, and LCx assays for detection of Chlamydia trachomatis infection in women by using urine specimens. J Clin Microbiol (1997) 2.73
T-cell lines producing antigen-specific suppressor factor. Nature (1978) 2.63
Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol (1991) 2.43
Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk. Diabetologia (2012) 2.41
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes (1999) 2.36
Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes (1996) 2.33
CNS manifestations of Nasu-Hakola disease: a frontal dementia with bone cysts. Neurology (2001) 2.27
The human p50csk tyrosine kinase phosphorylates p56lck at Tyr-505 and down regulates its catalytic activity. EMBO J (1992) 2.16
A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes (1995) 2.08
Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring. Diabetologia (2010) 2.08
West syndrome: individualized ACTH therapy. Brain Dev (1997) 2.07
Suppressor cell induction in vitro. II. Cellular requirements of suppressor cell induction. Eur J Immunol (1976) 2.05
The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia (2002) 1.99
Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group. J Clin Invest (1998) 1.91
Clinical presentation and outcome of listeriosis in patients with and without immunosuppressive therapy. Clin Infect Dis (1992) 1.90
Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes (2000) 1.90
Detection of Chlamydia trachomatis infections in women by Amplicor PCR: comparison of diagnostic performance with urine and cervical specimens. J Clin Microbiol (1996) 1.89
Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children. Clin Exp Allergy (2009) 1.87
Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein. Am J Hum Genet (2000) 1.87
Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes (1994) 1.82
Cellular origin and differentiation of renal carcinomas. A fluorescence microscopic study with kidney-specific antibodies, antiintermediate filament antibodies, and lectins. Lab Invest (1983) 1.82
Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort. Diabetologia (2001) 1.82
Fructose-induced hyperuricaemia. Lancet (1967) 1.80
Chlamydial endometritis. J Clin Pathol (1985) 1.80
Suppressor-cell induction in vitro. IV. Target of antigen-specific suppressor factor and its genetic relationships. J Exp Med (1978) 1.77
Quantitative MRI of the hippocampus and amygdala in severe depression. Psychol Med (2000) 1.77
Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet (1998) 1.77
Long term outcome of temporal lobe epilepsy surgery: analyses of 140 consecutive patients. J Neurol Neurosurg Psychiatry (2002) 1.76
Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes. Diabetes Care (2000) 1.76
Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neurol (1996) 1.75
Evaluation of the Gen-Probe Chlamydia trachomatis transcription-mediated amplification assay with urine specimens from women. J Clin Microbiol (1997) 1.74
Biogenesis of podocalyxin--the major glomerular sialoglycoprotein--in the newborn rat kidney. Eur J Cell Biol (1989) 1.74
Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors. Scand J Gastroenterol (1998) 1.72
Obesity, increased linear growth, and risk of type 1 diabetes in children. Diabetes Care (2000) 1.70
Detection of Mycobacterium tuberculosis complex in sputum specimens by the automated Roche Cobas Amplicor Mycobacterium Tuberculosis Test. J Clin Microbiol (1998) 1.68
Suppressor cell induction in vitro. I. Kinetics of induction of antigen-specific suppressor cells. Eur J Immunol (1976) 1.65
Microbiological and histopathological findings in acute pelvic inflammatory disease. Br J Obstet Gynaecol (1987) 1.65
Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization. Blood (1992) 1.65
Amplification of fgfr4 gene in human breast and gynecological cancers. Int J Cancer (1993) 1.63
Gene encoding a new RING-B-box-Coiled-coil protein is mutated in mulibrey nanism. Nat Genet (2000) 1.63
Serum CA 125 in acute pelvic inflammatory disease. Br J Obstet Gynaecol (1989) 1.62
Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest (1995) 1.60
Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. J Clin Endocrinol Metab (1996) 1.59
Celiac disease and autoimmune endocrinologic disorders. Dig Dis Sci (1999) 1.58
Non-class II HLA gene associated with type 1 diabetes maps to the 240-kb region near HLA-B. Diabetes (2000) 1.58
Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects. Neurology (1999) 1.57
Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis. J Exp Med (1992) 1.56
Expression of vimentin and cytokeratin types of intermediate filament proteins in developing and adult human kidneys. Lab Invest (1984) 1.56
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55
An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21. Nat Genet (1994) 1.53
Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot study. Diabetologia (2005) 1.52
The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes. Diabetologia (2001) 1.51
Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes. Diabetologia (2011) 1.51
Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits. Gut (2006) 1.51
Coffee consumption and the risk of latent autoimmune diabetes in adults--results from a Swedish case-control study. Diabet Med (2014) 1.51
Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle. Diabetologia (2008) 1.50
Protein intolerance with deficient transport of basic aminoacids. Another inborn error of metabolism. Lancet (1965) 1.50
Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes Prediction and Prevention Study. Diabetes (2000) 1.50
CSF and MRI findings in patients with acute herpes zoster. Neurology (1998) 1.49
Validity and reproducibility of a food frequency questionnaire for pregnant Finnish women. Am J Epidemiol (2001) 1.49
Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment. Diabetologia (2010) 1.48
Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy. Ann Neurol (1999) 1.46
Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J Intern Med (2009) 1.45
The mouse tie receptor tyrosine kinase gene: expression during embryonic angiogenesis. Oncogene (1994) 1.45
Lectins as fluorescence microscopic markers for saccharides in the human kidney. Lab Invest (1981) 1.45
Celiac disease without villous atrophy: revision of criteria called for. Dig Dis Sci (2001) 1.44
Ulex europaeus I lectin as a marker for tumors derived from endothelial cells. Am J Clin Pathol (1983) 1.44
Relation among mannose-binding lectin 2 genotype, beta-cell autoantibodies, and risk for type 1 diabetes in Finnish children. Hum Immunol (2008) 1.42
Islet cell-specific autoantibodies in children with insulin-dependent diabetes mellitus and their siblings at clinical manifestation of the disease. Childhood Diabetes in Finland Study Group. Eur J Endocrinol (1996) 1.42
Prolonged exclusive breast feeding and heredity as determinants in infantile atopy. Arch Dis Child (1987) 1.42
Population-based genetic screening for the estimation of Type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci. Diabet Med (1999) 1.42
Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes--indication of an increased environmental pressure? Diabetologia (2003) 1.41
Anatomic sites of upper genital tract infection. Obstet Gynecol (1985) 1.41
Age at introduction of new foods and advanced beta cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes. Diabetologia (2006) 1.41
Collagen metabolites in the prediction of response to GH therapy in short children. Eur J Endocrinol (1997) 1.40
Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int (1996) 1.40
Nephrin localizes at the podocyte filtration slit area and is characteristically spliced in the human kidney. Am J Pathol (1999) 1.40
Soluble adhesion molecules in preclinical type 1 diabetes. The Childhood Diabetes in Finland Study Group. Pediatr Res (2001) 1.40
HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families. Tissue Antigens (2003) 1.39
Mycoplasmas and leukaemia. Res Virol (1992) 1.39
T cell responses to PPD in BCG-vaccinated children with insulin-dependent diabetes mellitus and controls. Acta Paediatr (1994) 1.39
Heymann nephritis induced by kidney brush border glycoproteins. Lab Invest (1980) 1.39
Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease. Aliment Pharmacol Ther (2006) 1.39
Involvement of lipid rafts in nephrin phosphorylation and organization of the glomerular slit diaphragm. Am J Pathol (2001) 1.39
A model for the involvement of MHC class II proteins in the development of type 1 (insulin-dependent) diabetes mellitus in response to bovine serum albumin peptides. Diabetologia (1993) 1.39
Conditions for inducing T helper cells in vitro. Scand J Immunol (1975) 1.39
Absence of IgA and growth hormone deficiency associated with short arm deletion of chromosome 18. Arch Dis Child (1973) 1.38
Death of a young woman suffering from primary pulmonary hypertension during inhaled nitric oxide therapy. Arch Intern Med (1995) 1.38